COG ALTE1621: Pharmacologic Reversal of Ventricular Remodeling in Childhood CancerSurvivors at Risk for Heart Failure (PREVENT-HF): A Phase 2b Randomized Placebo-Controlled (Carvedilol) Trial

Project: Research project

Project Details

StatusFinished
Effective start/end date12/1/16 → 11/30/21

Funding

  • Children’s Hospital of Philadelphia
  • National Cancer Institute